| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0005 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | 0.19 | 0.0007 |
| mRNA | LY-2183240 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0007 |
| mRNA | AZD-2281 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0007 |
| mRNA | OSI-930 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.0007 |
| mRNA | Compound 7d-cis | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0008 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.54 | 0.0008 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.0009 |